Drug Profile
SEP 228425
Alternative Names: SEP-225425; SEP-228425Latest Information Update: 14 Jul 2009
Price :
$50
*
At a glance
- Originator Sepracor
- Class Antidepressants
- Mechanism of Action Adrenergic receptor antagonists; Dopamine uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder; Pain
Most Recent Events
- 31 Dec 2008 Discontinued - Phase-I for Depression in USA (unspecified route)
- 31 Dec 2008 Discontinued - Phase-I for Pain in USA (unspecified route)
- 30 Jun 2008 Phase-I clinical trials in Depression in USA (unspecified route)